184 related articles for article (PubMed ID: 8821850)
1. Maternal serum screening for fetal Down syndrome in IVF pregnancies.
Ribbert LS; Kornman LH; De Wolf BT; Simons AH; Jansen CA; Beekhuis JR; Mantingh A
Prenat Diagn; 1996 Jan; 16(1):35-8. PubMed ID: 8821850
[TBL] [Abstract][Full Text] [Related]
2. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
3. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
Frishman GN; Canick JA; Hogan JW; Hackett RJ; Kellner LH; Saller DN
Obstet Gynecol; 1997 Jul; 90(1):98-101. PubMed ID: 9207822
[TBL] [Abstract][Full Text] [Related]
4. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
5. Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies.
Räty R; Virtanen A; Koskinen P; Laitinen P; Forsström J; Salonen R; Mörsky P; Ekblad U
Prenat Diagn; 2000 Mar; 20(3):221-3. PubMed ID: 10719325
[TBL] [Abstract][Full Text] [Related]
6. Cell-free fetal DNA levels in pregnancies conceived by IVF.
Pan PD; Peter I; Lambert-Messerlian GM; Canick JA; Bianchi DW; Johnson KL
Hum Reprod; 2005 Nov; 20(11):3152-6. PubMed ID: 16006472
[TBL] [Abstract][Full Text] [Related]
7. Dependence of maternal serum [AFP]/[hCG] median ratios on age of gestation: comparison of trisomy 21 to euploid pregnancies.
Marcus-Braun N; Birk O; Manor E; Segal D; Harari G; Toma I; Shalev S; Borochowitz ZU; Yaron Y; Sharony R; Itzhaky D; Shtoyerman R; Appelman Z; Braun G
Prenat Diagn; 2009 Dec; 29(12):1130-4. PubMed ID: 19777489
[TBL] [Abstract][Full Text] [Related]
8. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
9. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
10. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
Liao S; Wang Y; Ye G
Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
[TBL] [Abstract][Full Text] [Related]
11. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome.
Muller F; Dreux S; Lemeur A; Sault C; Desgrès J; Bernard MA; Giorgetti C; Lemay C; Mirallié S; Beauchet A;
Prenat Diagn; 2003 Dec; 23(13):1073-6. PubMed ID: 14691995
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic cholestasis of pregnancy has no effect on maternal serum second trimester alpha-fetoprotein and hCG.
Eloranta ML; Heinonen S; Kirkinen P
Acta Obstet Gynecol Scand; 2000 Jul; 79(7):548-52. PubMed ID: 10929953
[TBL] [Abstract][Full Text] [Related]
13. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
Spencer K
Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies.
Ognibene A; Ciuti R; Tozzi P; Messeri G
Prenat Diagn; 1999 Nov; 19(11):1058-60. PubMed ID: 10589060
[TBL] [Abstract][Full Text] [Related]
15. Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies.
Maymon R; Shulman A
Prenat Diagn; 2004 Feb; 24(2):125-9. PubMed ID: 14974121
[TBL] [Abstract][Full Text] [Related]
16. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
17. 46,XY,i(21q) identified by maternal serum screening.
Meyers CM; Ghori S; Roberson AE; Blitzer MG; Cohen MM
Md Med J; 1997 Feb; 46(2):88-9. PubMed ID: 9029908
[TBL] [Abstract][Full Text] [Related]
18. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum markers levels in consecutive pregnancies: a possible genetic predisposition to abnormal levels.
Dar H; Merksamer R; Berdichevsky D; David M
Am J Med Genet; 1996 Jan; 61(2):154-7. PubMed ID: 8669443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]